UnitedHealth’s Q2 results and upward EPS revision drive shares higher amid broader market weakness in tech stocks.
UnitedHealth Group (UNH) surged after reporting stronger-than-expected Q2 earnings and raising its full-year EPS guidance. The healthcare giant’s performance bolstered investor confidence, contrasting with declines in major indexes like the S&P 500 and Nasdaq, which retreated from earlier gains due to global tech sector weakness.
U.S. retail sales growth slowed in June, with core sales declining and gasoline sales weakening. The data suggests cooling consumer demand, potentially impacting retail stocks and broader economic sentiment. Markets had anticipated modest growth, but the softer print may influence expectations for future Federal Reserve policy.
Wall Street’s mixed session reflected cautious trading, with technology stocks under pressure. The S&P 500 and Nasdaq both erased earlier gains, while UnitedHealth’s outperformance highlighted sector-specific resilience.